Report cover image

Biosimilar Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

Publisher Prof-Research
Published May 23, 2023
Length 108 Pages
SKU # PROF17957655

Description

Biosimilar Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type


This report describes the global market size of Biosimilar Drug from 2018 to 2022 and its CAGR from 2018 to 2022, and also forecasts its market size to the end of 2028 and its CAGR from 2023 to 2028.

For geography segment, regional supply, demand, major players, price is presented from 2018 to 2028. This report cover following regions:
North America
South America
Asia & Pacific
Europe
MEA

The key countries for each regions are also included such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For competitor segment, the report include global key players of Biosimilar Drug as well as some small players. The information for each competitor include:
Company Profile
Business Information
SWOT Analysis
Revenue, Gross Margin and Market Share

Applications Segment:
Tumor
Diabetes
Cardiovascular
Hemophilia
Other

Types Segment:
Antibody
Hormone
Growth Factors
Other

Companies Covered:
Pfizer
Roche
Eli Lilly
Bayer
Amgen
Sanofi-Aventis
Johnson& Johnson
Novo Nordisk
Merck
etc.

Please ask for sample pages for full companies list

Base Year: 2023
Historical Data: from 2018 to 2022
Forecast Data: from 2023 to 2028

Table of Contents

108 Pages
Chapter 1 Executive Summary
Chapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 Covid-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Biosimilar Drug Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Biosimilar Drug Market in North America (2018-2028)
8.1 Biosimilar Drug Market Size
8.2 Biosimilar Drug Market by End Use
8.3 Competition by Players/Suppliers
8.4 Biosimilar Drug Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Biosimilar Drug Market in South America (2018-2028)
9.1 Biosimilar Drug Market Size
9.2 Biosimilar Drug Market by End Use
9.3 Competition by Players/Suppliers
9.4 Biosimilar Drug Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Biosimilar Drug Market in Asia & Pacific (2018-2028)
10.1 Biosimilar Drug Market Size
10.2 Biosimilar Drug Market by End Use
10.3 Competition by Players/Suppliers
10.4 Biosimilar Drug Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southest Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Biosimilar Drug Market in Europe (2018-2028)
11.1 Biosimilar Drug Market Size
11.2 Biosimilar Drug Market by End Use
11.3 Competition by Players/Suppliers
11.4 Biosimilar Drug Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Biosimilar Drug Market in MEA (2018-2028)
12.1 Biosimilar Drug Market Size
12.2 Biosimilar Drug Market by End Use
12.3 Competition by Players/Suppliers
12.4 Biosimilar Drug Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Biosimilar Drug Market (2018-2023)
13.1 Biosimilar Drug Market Size
13.2 Biosimilar Drug Market by End Use
13.3 Competition by Players/Suppliers
13.4 Biosimilar Drug Market Size by Type
Chapter 14 Global Biosimilar Drug Market Forecast (2023-2028)
14.1 Biosimilar Drug Market Size Forecast
14.2 Biosimilar Drug Application Forecast
14.3 Competition by Players/Suppliers
14.4 Biosimilar Drug Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Pfizer
15.1.1 Company Profile
15.1.2 Main Business and Biosimilar Drug Information
15.1.3 SWOT Analysis of Pfizer
15.1.4 Pfizer Biosimilar Drug Revenue, Gross Margin and Market Share (2018-2023)
15.2 Roche
15.2.1 Company Profile
15.2.2 Main Business and Biosimilar Drug Information
15.2.3 SWOT Analysis of Roche
15.2.4 Roche Biosimilar Drug Revenue, Gross Margin and Market Share (2018-2023)
15.3 Eli Lilly
15.3.1 Company Profile
15.3.2 Main Business and Biosimilar Drug Information
15.3.3 SWOT Analysis of Eli Lilly
15.3.4 Eli Lilly Biosimilar Drug Revenue, Gross Margin and Market Share (2018-2023)
15.4 Bayer
15.4.1 Company Profile
15.4.2 Main Business and Biosimilar Drug Information
15.4.3 SWOT Analysis of Bayer
15.4.4 Bayer Biosimilar Drug Revenue, Gross Margin and Market Share (2018-2023)
15.5 Amgen
15.5.1 Company Profile
15.5.2 Main Business and Biosimilar Drug Information
15.5.3 SWOT Analysis of Amgen
15.5.4 Amgen Biosimilar Drug Revenue, Gross Margin and Market Share (2018-2023)
15.6 Sanofi-Aventis
15.6.1 Company Profile
15.6.2 Main Business and Biosimilar Drug Information
15.6.3 SWOT Analysis of Sanofi-Aventis
15.6.4 Sanofi-Aventis Biosimilar Drug Revenue, Gross Margin and Market Share (2018-2023)
15.7 Johnson& Johnson
15.7.1 Company Profile
15.7.2 Main Business and Biosimilar Drug Information
15.7.3 SWOT Analysis of Johnson& Johnson
15.7.4 Johnson& Johnson Biosimilar Drug Revenue, Gross Margin and Market Share (2018-2023)
15.8 Novo Nordisk
15.8.1 Company Profile
15.8.2 Main Business and Biosimilar Drug Information
15.8.3 SWOT Analysis of Novo Nordisk
15.8.4 Novo Nordisk Biosimilar Drug Revenue, Gross Margin and Market Share (2018-2023)
15.9 Merck
15.9.1 Company Profile
15.9.2 Main Business and Biosimilar Drug Information
15.9.3 SWOT Analysis of Merck
15.9.4 Merck Biosimilar Drug Revenue, Gross Margin and Market Share (2018-2023)
Please ask for sample pages for full companies list
 
Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Biosimilar Drug Report
Table Data Sources of Biosimilar Drug Report
Table Major Assumptions of Biosimilar Drug Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Biosimilar Drug Picture
Table Biosimilar Drug Classification
Table Biosimilar Drug Applications
Table Drivers of Biosimilar Drug Market
Table Restraints of Biosimilar Drug Market
Table Opportunities of Biosimilar Drug Market
Table Threats of Biosimilar Drug Market
Table Covid-19 Impact For Biosimilar Drug Market
Table Raw Materials Suppliers
Table Different Production Methods of Biosimilar Drug
Table Cost Structure Analysis of Biosimilar Drug
Table Key End Users
Table Latest News of Biosimilar Drug Market
Table Merger and Acquisition
Table Planned/Future Project of Biosimilar Drug Market
Table Policy of Biosimilar Drug Market
Table 2018-2028 North America Biosimilar Drug Market Size
Figure 2018-2028 North America Biosimilar Drug Market Size and CAGR
Table 2018-2028 North America Biosimilar Drug Market Size by Application
Table 2018-2023 North America Biosimilar Drug Key Players Revenue
Table 2018-2023 North America Biosimilar Drug Key Players Market Share
Table 2018-2028 North America Biosimilar Drug Market Size by Type
Table 2018-2028 United States Biosimilar Drug Market Size
Table 2018-2028 Canada Biosimilar Drug Market Size
Table 2018-2028 Mexico Biosimilar Drug Market Size
Table 2018-2028 South America Biosimilar Drug Market Size
Figure 2018-2028 South America Biosimilar Drug Market Size and CAGR
Table 2018-2028 South America Biosimilar Drug Market Size by Application
Table 2018-2023 South America Biosimilar Drug Key Players Revenue
Table 2018-2023 South America Biosimilar Drug Key Players Market Share
Table 2018-2028 South America Biosimilar Drug Market Size by Type
Table 2018-2028 Brazil Biosimilar Drug Market Size
Table 2018-2028 Argentina Biosimilar Drug Market Size
Table 2018-2028 Chile Biosimilar Drug Market Size
Table 2018-2028 Peru Biosimilar Drug Market Size
Table 2018-2028 Asia & Pacific Biosimilar Drug Market Size
Figure 2018-2028 Asia & Pacific Biosimilar Drug Market Size and CAGR
Table 2018-2028 Asia & Pacific Biosimilar Drug Market Size by Application
Table 2018-2023 Asia & Pacific Biosimilar Drug Key Players Revenue
Table 2018-2023 Asia & Pacific Biosimilar Drug Key Players Market Share
Table 2018-2028 Asia & Pacific Biosimilar Drug Market Size by Type
Table 2018-2028 China Biosimilar Drug Market Size
Table 2018-2028 India Biosimilar Drug Market Size
Table 2018-2028 Japan Biosimilar Drug Market Size
Table 2018-2028 South Korea Biosimilar Drug Market Size
Table 2018-2028 Southeast Asia Biosimilar Drug Market Size
Table 2018-2028 Australia Biosimilar Drug Market Size
Table 2018-2028 Europe Biosimilar Drug Market Size
Figure 2018-2028 Europe Biosimilar Drug Market Size and CAGR
Table 2018-2028 Europe Biosimilar Drug Market Size by Application
Table 2018-2023 Europe Biosimilar Drug Key Players Revenue
Table 2018-2023 Europe Biosimilar Drug Key Players Market Share
Table 2018-2028 Europe Biosimilar Drug Market Size by Type
Table 2018-2028 Germany Biosimilar Drug Market Size
Table 2018-2028 France Biosimilar Drug Market Size
Table 2018-2028 United Kingdom Biosimilar Drug Market Size
Table 2018-2028 Italy Biosimilar Drug Market Size
Table 2018-2028 Spain Biosimilar Drug Market Size
Table 2018-2028 Belgium Biosimilar Drug Market Size
Table 2018-2028 Netherlands Biosimilar Drug Market Size
Table 2018-2028 Austria Biosimilar Drug Market Size
Table 2018-2028 Poland Biosimilar Drug Market Size
Table 2018-2028 Russia Biosimilar Drug Market Size
Table 2018-2028 MEA Biosimilar Drug Market Size
Figure 2018-2028 MEA Biosimilar Drug Market Size and CAGR
Table 2018-2028 MEA Biosimilar Drug Market Size by Application
Table 2018-2023 MEA Biosimilar Drug Key Players Revenue
Table 2018-2023 MEA Biosimilar Drug Key Players Market Share
Table 2018-2028 MEA Biosimilar Drug Market Size by Type
Table 2018-2028 Egypt Biosimilar Drug Market Size
Table 2018-2028 Israel Biosimilar Drug Market Size
Table 2018-2028 South Africa Biosimilar Drug Market Size
Table 2018-2028 Gulf Cooperation Council Countries Biosimilar Drug Market Size
Table 2018-2028 Turkey Biosimilar Drug Market Size
Table 2018-2023 Global Biosimilar Drug Market Size by Region
Table 2018-2023 Global Biosimilar Drug Market Size Share by Region
Table 2018-2023 Global Biosimilar Drug Market Size by Application
Table 2018-2023 Global Biosimilar Drug Market Share by Application
Table 2018-2023 Global Biosimilar Drug Key Vendors Revenue
Figure 2018-2023 Global Biosimilar Drug Market Size and Growth Rate
Table 2018-2023 Global Biosimilar Drug Key Vendors Market Share
Table 2018-2023 Global Biosimilar Drug Market Size by Type
Table 2018-2023 Global Biosimilar Drug Market Share by Type
Table 2023-2028 Global Biosimilar Drug Market Size by Region
Table 2023-2028 Global Biosimilar Drug Market Size Share by Region
Table 2023-2028 Global Biosimilar Drug Market Size by Application
Table 2023-2028 Global Biosimilar Drug Market Share by Application
Table 2023-2028 Global Biosimilar Drug Key Vendors Revenue
Figure 2023-2028 Global Biosimilar Drug Market Size and Growth Rate
Table 2023-2028 Global Biosimilar Drug Key Vendors Market Share
Table 2023-2028 Global Biosimilar Drug Market Size by Type
Table 2023-2028 Biosimilar Drug Global Market Share by Type

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us